Mercaptor Discoveries Uses its Proprietary Neurotherapeutic Platform to Develop Treatment for COVID-19

NOVATO, Calif., May 18, 2020 /PRNewswire/ — Mercaptor Discoveries (Mercaptor), a platform company with preclinical programs in epilepsy and TBI, today announced that it is pivoting its proprietary neurotherapeutic development plan toward COVID-19. While emphasis has been on systemic viral mechanisms of respiratory failure, COVID-19 is also a neurotropic virus, triggering neuroinflammation in the brainstem that is […]